Anita Dushyanth
Stock Analyst at Berenberg
(2.81)
# 1,605
Out of 4,818 analysts
4
Total ratings
75%
Success rate
15.74%
Average return
Main Sectors:
Stocks Rated by Anita Dushyanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| URGN UroGen Pharma | Initiates: Buy | $20 | $10.24 | +95.31% | 1 | Apr 27, 2022 | |
| SERA Sera Prognostics | Initiates: Buy | $13 | $3.44 | +277.91% | 1 | Apr 27, 2022 | |
| BTAI BioXcel Therapeutics | Initiates: Buy | $1,200 | $1.70 | +70,488.24% | 1 | Apr 9, 2021 | |
| PCRX Pacira BioSciences | Initiates: Buy | $93 | $25.21 | +268.90% | 1 | Apr 9, 2021 |
UroGen Pharma
Apr 27, 2022
Initiates: Buy
Price Target: $20
Current: $10.24
Upside: +95.31%
Sera Prognostics
Apr 27, 2022
Initiates: Buy
Price Target: $13
Current: $3.44
Upside: +277.91%
BioXcel Therapeutics
Apr 9, 2021
Initiates: Buy
Price Target: $1,200
Current: $1.70
Upside: +70,488.24%
Pacira BioSciences
Apr 9, 2021
Initiates: Buy
Price Target: $93
Current: $25.21
Upside: +268.90%